Skip to content
healthcare.dev

GUAIFENESIN

NDC 70010-199, GUAIFENESIN, tablet, extended release, from GRANULES PHARMACEUTICALS INC..

Product NDC
70010-199
Status
Listed
Labeler
GRANULES PHARMACEUTICALS INC.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA213420
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70010-199 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GUAIFENESIN600 mg/1

Pharmacologic classes

Decreased Respiratory Secretion Viscosity [PE]; Expectorant [EPC]; Increased Respiratory Secretions [PE]

Package NDCNDC-11Package
70010-199-0570010019905500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-199-05)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • NADAC price for package 70010019905

    GET /v1/drugs/nadac/70010019905

Use it

Look up 70010-199 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70010-199 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70010-199. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.